Clinical Trials Logo

Morquio Syndrome A clinical trials

View clinical trials related to Morquio Syndrome A.

Filter by:
  • None
  • Page 1

NCT ID: NCT03632213 Active, not recruiting - Clinical trials for Mucopolysaccharidosis VI

Evaluation of Losartan on Cardiovascular Disease in Patients With Mucopolysaccharidoses IV A and VI

Start date: November 7, 2018
Phase: Phase 2
Study type: Interventional

Mucopolysaccharidoses (MPS) are multisystemic diseases with significant clinical overlap between their types, with cardiac problems being among the most commonly observed manifestations and are also among the main causes of mortality in these patients. For some of the cardiovascular manifestations, such as aortic root dilation and valve diseases, there is no effective treatment currently available. Losartan, on the other hand, has been shown to be an effective drug for dilation of the aortic root, at least in animal models. This study aims to evaluate the safety and efficacy of losartan in patients with MPS VI and other mucopolysaccharidoses.

NCT ID: NCT01961518 Completed - MPS IVA Clinical Trials

Screening an Orthopedic Population for Mildly-affected Individuals With Morquio Syndrome A and Maroteaux-Lamy Syndrome

Start date: October 2013
Phase: N/A
Study type: Observational

The purpose of this study is to identify patients with Morquio syndrome type A (MPS IVA) and Maroteaux-Lamy syndrome (MPS VI) who may have been missed or misdiagnosed due to atypical clinical features, a milder course, and/or negative urine screening. We will recruit participants who have certain hip and/or joint problems that could potentially be caused by one of these two genetic conditions through a chart review process conducted at Shriners Hospital for Children in Greenville, SC. Diagnostic testing will be performed for each participant to determine if he or she is affected by one of these two conditions. Results will be disclosed to all participants and their legal guardians, and appropriate follow up will be recommended for those who are found to have abnormal results.

NCT ID: NCT01457456 Withdrawn - Morquio B Disease Clinical Trials

Biomarker for Morquio Disease (BioMorquio)

BioMorquio
Start date: August 20, 2018
Phase:
Study type: Observational

Development of a new MS-based biomarker for the early and sensitive diagnosis of Morquio disease from plasma